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Increased neurogenesis in feeding centers of the murine hypothalamus is associated with weight loss in diet-induced obese rodents
(Kokoeva et al., 2005 and Matrisciano et al., 2010), but this relationship has not been examined in other species. Postmortem
hippocampal neurogenesis rates and premortem metabolic parameters were statistically analyzed in 8 chow-fed colony-reared
adult bonnet macaques. Dentate gyrus neurogenesis, reﬂected by the immature neuronal marker, doublecortin (DCX), and ex-
pressionoftheantiapoptoticgenefactor,B-celllymphoma2(BCL-2),butnottheprecursorproliferationmitoticmarker,Ki67,was
inversely correlated with body weight and crown-rump length. DCX and BCL-2 each correlated positively with blood glucose level
and lipid ratio (total cholesterol/high-density lipoprotein). This study demonstrates that markers of dentate gyrus neuroplasticity
correlate with metabolic parameters in primates.
1.Introduction
The hippocampus is receiving increasing attention for its
potential role in energy regulation [1]. The hippocampus is
part of a neural circuit involved with reward and energy
regulation [2] and is sensitive to satiety signals associated
with learning and memory [3]. Recent ﬁndings indicate that
palatable high-fat diets promote excessive food intake and
weight gain and interfere with hippocampal functioning.
This is supported by epidemiological data linking diets high
in saturated fat with weight gain and memory deﬁcits [4–6].
Furthermore, rats and humans with diabetes mellitus show
age-related performance impairments on memory tasks [7].
More recent studies demonstrate that high-fat diet-induced
maternal obesity impairs oﬀspring hippocampal BDNF pro-
duction [8], alters fetal hippocampal development [9], and
reduces hippocampal neurogenesis during the early life of
their oﬀspring [10]. Moreover, adult male rats fed with a
high-fat diet show impaired hippocampal neurogenesis [11].
Neurogenesis induced by ciliary neurotrophic factor(CNTF)
orbrain-derivedneurotrophicfactor(BDNF)infeedingcen-
ters of the murine hypothalamus is associated with weight
loss in obese rodents [12, 13]. Because both hippocampal
neurogenesis and proxy metabolic parameters are connected
with stress and mood disorders [14–16], the aforementioned
hypothalamic data raise important questions regarding the
relationship between hippocampal neurogenesis and the
regulation of peripheral metabolic parameters. We present
a pilot study of the relationship between hippocampal
neurogenesis and metabolic parameters in adult nonhuman
primates.
2. Methods
2.1. Subjects. All animal work has been conducted according
to relevant national and international guidelines. In accor-
dance with the recommendations of the Weatherall report2 Neural Plasticity
“The use of nonhuman primates in research”, the following
statement to this eﬀect has been included to document
the details of animal welfare and steps taken to ameliorate
suﬀering in all work involving non-human primates. This
work was conducted at the Nonhuman Primate Facility of
the State University of New York Downstate Medical Center
with permission from its Institutional Animal Care and Use
Committee (IACUC).
2.2. Adverse Rearing Paradigm. Singly housed adult male
bonnet macaques with a history of adverse rearing during
infancy (N = 4) or normal rearing during infancy (N = 4)
were matched for age and weight. The rearing conditions
were established in previous studies [17, 18]. Adult subjects
with a history of adverse rearing during infancy were
those whose mothers were exposed to Variable Foraging
Demand (VFD) conditions that involved alternating 2-week
periods of easy and diﬃcult food foraging conditions for
a total of 16 weeks. The control subjects had mothers that
were exposed to Low Foraging Demand (LFD) (control)
conditions throughout this period.
2.3. Morphometry. During anesthesia for blood sampling,
weight in kilograms and crown-rump length (CRL) were
measured, where CRL was the length in centimeters from the
vertex of the head to the base of the tail. Measurements were
consistently performed by the same team of investigators
blinded to rearing condition as reported in an earlier study
[19].
2.4. Blood Chemistry. Using previous methods [19], venous
blood was drawn in plain nonheparinized tubes between
0800–1100h after an overnight fast. On the day before
blood sampling, food was withdrawn at 1600h, and water
remained available ad libitum. Monkeys were individually
captured in carrying cages, placed in single-animal squeeze
cages, and anesthetized with ketamine (10–15mg/kg). Blood
from antecubital or femoral veins was immediately placed
on ice, centrifuged for serum separation, and stored at
−80◦C within 1h. Samples were analyzed in one batch by
routine laboratory procedures at the University Hospital of
Brooklyn Clinical Chemistry Laboratory. Serum glucose was
measured by glucose oxidase; serum triglycerides (TGs) were
determined enzymatically using Ektachem Clinical Chem-
istry Slide; high-density lipoprotein (HDL), low-density
lipoprotein (LDL), and total cholesterol were measured
using the Vitros Chemistry Magnetic Reagent (Clinical
Diagnostics Operator’s Manual 1995, Johnson & Johnson,
New Brunswick, NJ).
2.5. Neurohistochemistry. After obtaining blood samples and
morphometry, all subjects were euthanized using established
methods [14, 20]. Brieﬂy, the subjects were anesthetized to
a surgical depth with sodium pentothal and transcardially
perfused with saline and formalin. The brains were removed
and postﬁxed in 4% paraformaldehyde for immunnohisto-
chemicalstainingandanalysis.Thelefthippocampuswascut
into 40µm sections. Every 40th section (approximately 10–
12 sections per antibody) through the rostrocaudal extent
of the left hippocampus was immunostained with standard
peroxidase to detect and quantify cell proliferation and neu-
rogenesis rates using our previous methods [14, 20]. Stan-
dard peroxidase methods were used to determine the follow-
ing: granule cells proliferating at the time of sacriﬁce iden-
tiﬁed by the expression of the mitotic marker Ki67 (mouse
anti-Ki67 antibody, 1:200; Vector Laboratories, Burlingame,
CA) or B-cell chronic lymphocytic lymphoma 2 (BCL2)
(anti-BCL2 (1:200); Dako, High Wycombe, UK); new
neurons that were still immature, detected by the expression
of the microtubule-associated protein doublecortin (DCX)
[20] (goat anti-doublecortin, 1:200; Santa Cruz, CA). The
secondary antibody is biotinylated anti-mouse IgG (1:200;
Vector Laboratories, Burlingame, CA), and was visualized
with avidin-biotin complex solution (Vector Laboratories,
Burlingame, CA) and diaminobenzidine (DAB; Sigma-Al-
drich, St Louis, MO). The density of DCX- or Ki67- labeled
cells per mm3 of the SGZ was estimated for each animal.
Expression of BCL2 in the SGZ was semiquantitatively
graded using a previously established four-point rating scale
method [14]. Two independent raters, masked to treatment
condition, counted all of unambiguously Ki67 or DCX-
labeled cells in the subgranular zone (SGZ) of the dentate
gyrus (deﬁned as a two-cell-body-wide zone on either side
of the border of the granule cell layer) using a 40x objective
(Figure 1(a)).
2.6. Quantiﬁcation and Statistical Analyses. Only DCX ex-
pressing cells that had tertiary dendrites were counted
(Figure 1(a) panel B). Based on established methods [14],
the density of Ki67 or DCX labeled cells was calculated.
The density was deﬁned as the number of positively stained
cells divided by the volume of the SGZ. The volume of
the SGZ was calculated as the length of the SGZ (per
section) multiplied by the thickness of each section (40µm)
multiplied by approximate width of two cells (50µm).
Given the diﬀuse nature of BCL2 labeling, a previously
established 4-point semiquantitative rating scale was used
to evaluate the extent of BCL2 expression [14]. BCL2 gene
expression in the SGZ was rated according to the following:
(A) represents no labeling; rated as 0. (B) represents light
labeling of individual cells; rated as 1. (C) represents heavy,
yet noncontinuous labeling of BCL-2 along the SGZ; rated as
2. (D)represents intense labeling forming a continuous band
along the entire length of the SGZ; rated as 3.
Pearson correlation analyses were used to elucidate the
relation among morphometric indices (body weight, crown-
rump length), metabolic parameters (blood glucose and
plasma lipids and lipid ratio), and neurogenesis markers
(dentate gyrus DCX, BCL-2 and Ki67). A general linear
model was used to assess whether the eﬀects of body mass
were independent of age.
3. Results
Th eag eran g ef o ralls u bj ect swas9t o1 2y e ar so l dwi t hV F D -
reared subjects (mean age 11yrs, SD = 1.41) and LFD-reared
subjects (mean age 11yrs SD = 1.41) showing no diﬀerence
(df = 6, P = 1.0). The weight range was 5.5 to 14kg withNeural Plasticity 3
Table 1: Descriptive statistics of study variables.
(a) Histological ﬁndings in subjects exposed to adverse rearing (VFD) and normal control conditions (LFDs)
Subjects VFD LFD controls Statistics
Parameter N Mean Std Dev N Mean Std Dev t-value df P-value
Age (year) 4 11 1.41 4 11 .41 0 6 1
Weight (kg) 4 11.51 2.8 4 9.38 2.91 −1.06 6 0.332
Ki67 expressing cells (per mm3 of SGZ) 4 22.7 7.84 4 43.64 9.32 3.44 6 0.014
DCX expressing cells (per mm3 of SGZ) 4 75.43 96.42 4 262.5 116.33 2.48 6 0.048
BCL2 ratings (grades 1–4) 4 1.34 0.33 4 2.08 0.34 3.11 6 0.021
(b) Metabolic parameters in the subgroup of subjects
Parameter N Mean Std Dev
Glucose (mg/mL) 4 76.50 1.73
Crown Rump Length (cm) 4 19.81 1.28
Cholesterol (mg/dL) 4 117.50 21.23
Triglyceride (mg/dL) 4 50.00 20.03
HDL (mg/dL) 4 45.75 8.61
LDL (mg/dL) 4 61.75 22.20
Cholesterol/HDL ratio 4 2.63 0.74
(B)
(C) (D)
(A)
100µm 100µm
100µm 100µm
(a)
(B)
(C) (D)
(A)
500µm 500µm
500µm 500µm
(b)
Figure 1: Representative images of histological studies of the dentate gyrus of hippocampus. (a) Granule cells in the subgranular zone
(SGZ)positive (arrows)forDCX and Ki67.(A)represents negative control forDCX.(B)represents positivestainingfor DCX.(C)represents
negativecontrolforKi67.(D)representspositivestainingforKi67.Scalebar:100µm.(b)ImagesofBCL2-labeledcellsintheSGZ.BCL2gene
expression in the SGZ was rated using a semiquantitative according to a 4-point scale. (A) represents no labeling; rated as 0. (B) represents
light labeling of individual cells; rated as 1. (C) represents heavy, yet noncontinuous labeling of BCL-2 along the SGZ; rated as 2. (D)
represents intense labeling forming a continuous band along the entire length of the SGZ; rated as 3. Scale bar: 500µm.
VFD-reared (mean weight 11.5kg, SD = 2.79) and LFD-
reared subjects (mean weight 9.37kg, SD = 2.90) showing
no diﬀerence (df = 6; P = 0.33). Table 1 shows means and
standard deviations of individual parameters for all subjects,
and Figure 1 displays representative images of DCX, BCL-2,
and Ki67 positive cells.
There was a signiﬁcantly inverse correlation of body
weight with the number of DCX-stained neurons with ter-
tiary dendrites (r =− 0.76, P = 0.03, n = 8) and
BCL2-ratings of density (r =− 0.73, P = 0.041, n = 8)
(Figure 2).Usingagenerallinearmodel,itwasdemonstrated
that the relationship between DCX with tertiary dendrites4 Neural Plasticity
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Figure 2: Correlation between in vivo adult body mass and postmortem measures of neurogenesis levels and BCL2 Expression. (a) shows
a signiﬁcant inverse correlation (r =− 0.75, P = 0.03, n = 8) between body mass (in kilograms) and neurogenesis rates (indicated by
the density of DCX-stained neurons with tertiary dendrites in per mm3 in the SGZ). Regression line of both groups combined not shown.
(b)showsasigniﬁcant,inversecorrelation(r =− 0.73,P = 0.041,n = 8)between bodymass(inkilograms)andBCL2expressionintheSGZ
(determined by a 4-point rating scale). Regression line of both groups combined not shown. These results show that animals with higher
body mass have reduced neurogenesis rates and BCL-2. DCX: doublecortin; BCL-2: B-cell leukemia lymphoma 2. VFD: variable foraging
demand (adversely-reared); LFD: low foraging demand (normally reared).
Table 2: Pearson’s correlations between neurogenesis-related pa-
rameters in the dentate gyrus of the hippocampus and in vivo met-
abolic parameters (signiﬁcant at P<0.05).
BCL-2 Ki67 DCX
Glucose .99 .28 .99
P = 0.001 P = 0.71 P = 0.01
Cholesterol .28 −.61 .46
P = 0.71 P = 0.38 P = 0.53
Triglyceride
−.39 −.05 −.30
P = 0.60 P = 0.94 P = 0.69
HDL
−.88 −.31 −.81
P = 0.11 P = 0.68 P = 0.18
LDL .69 −.45 .81
P = 0.30 P = 0.54 P = 0.18
Ratio (total
Cholesterol/HDL)
.89 −.15 .96
P = 0.10 P = 0.84 P = 0.03
Crown-Rump
−.99 −.21 −.97
P = 0.006 P = 0.78 P = 0.02
Signiﬁcantﬁndingsarebolded.Therewasnosigniﬁcantcorrelationbetween
cell proliferation marker (Ki67) and metabolic parameters. DCX: double-
cortin; BCL-2: B-cell lymphoma 2; HDL: high-density lipoprotein; LDL:
low-density lipoprotein.
and weight remained all but signiﬁcant [F(1:5) = 6.34;
P = 0.053] for both LFD and VFD reared animals when
adjusted for age [F(1:5) = 1.18; P = 0.32]. Furthermore,
BCL-2 expression correlated with body weight [F(1:5) =
21.05; P = 0.006] for both LFD and VFD reared animals,
when adjusted for age [F(1:5) = 5.46; P = 0.067]. These
ﬁndingsindicatethatneuroplasticeﬀectsinthedentategyrus
weredependentuponarelationshiptobodymass,whichwas
independent of the eﬀects of age. There were also signiﬁcant
inverse correlations between the crown-rump length and
the number of DCX-stained neurons with tertiary dendrites
(r =− 0.98; P = 0.02, n = 4) and BCL2-ratings of density
(r =− 0.99; P = 0.006, n = 4) (Table 2). In addition, the
fasting serum glucose levels were positively correlated with
the DCX-stained neurons with tertiary dendrites (r = 0.97;
P = 0.021, n = 4) and the BCL2-ratings of density (r = 0.99;
P = 0.01, n = 4) (Table 2). The same was true for the blood
lipid ratio, but not individual lipid parameters, which also
positively correlated with DCX (r = 0.96; P = 0.042, n = 4),
but only at trend levels for BCL-2 (Table 2). There was no
signiﬁcant correlation between the cell proliferation marker,
Ki67, and metabolic parameters.
4. Discussion
Toourknowledge,thisistheﬁrstreporttoshowthatmarkers
of dentate gyrus neuroplasticity correlated with metabolic
parameters. However, precursor proliferation, as indicated
by Ki67, did not correlate with the metabolic parameters.
The results suggest that neurogenesis, but not precursor pro-
liferation, is associated with metabolic processes. Indicating
that the ﬁndings of the current study were not an artifact
of a possible relationship between body weight and central
parameters, our previous monkey MRI study revealed no
relationship between grey matter volume and body weight
[21].
Studies in rodents demonstrate that high-fat diet causing
weight gain impairs hippocampal neurogenesis through
increasedlipidperoxidationassociatedwithdecreasedBDNF
in the hippocampus [22, 23] and/or through glucocorticoid-
mediated eﬀects on immature or mature new neurons
[24,25].Inmice,genetic models deﬁcientofBDNFsignaling
exhibit hyperphagia and obesity [26] in addition to sup-
pressing hippopcampal neurogenesis [27]. In humans, obeseNeural Plasticity 5
children and adolescents exhibit reduced serum BDNF levels
relative to their normal weight counterparts [28, 29]. Both
central and peripheral administration of BDNF decrease
food intake, increase energy expenditure, and ameliorate
hyperglycemia in diabetic mice by a central nervous-system-
mediated mechanism [25, 28, 30]. The antidepressant eﬀects
of BDNF infusion are closely linked to the induction of
hippocampal neurogenesis [22]. Indeed, BDNF plays an
important role in regulation of neurogenesis, angiogenesis,
and synaptogenesis in the hippocampus [22, 31]. Therefore,
BDNF may be one of the common pathways mediating both
neurogenesis in the hippocampus and systemic metabolic
process, such as insulin resistance. Together these preclinical
and clinical ﬁndings imply an inverse correlation between
hippocampal neurogenesis and body weight.
Ourdataalsoshowedthatthehippocampalneurogenesis
correlated positively with blood glucose level and lipid ratio,
indicating that increased neurogenesis is associated with ele-
vated metabolic activity [31]. Under physiological con-
ditions, adult neurogenesis occurs within an angiogenic
niche—a microenviroment, providing metabolic support for
neurogenesis—within the hippocampus. The microenviron-
ment is modulated by the circulating system that supplies
mesenchymal stem cells and nutrients (e.g., glucose) [31].
Speciﬁc mechanisms linking hippocampal neurogenesis in-
teracting with the hypothalamus and regulating appetite and
intake behavior remain unclear.
Onepotentialcandidateforthecurrentlinkbetweenhip-
pocampalneurogenesisandmetabolicmarkersisleptin.Lep-
tin is a hormone secreted by adipose tissue and has eﬀects
at hypothalamic receptors that control food intake. Deﬁcits
in leptin or leptin receptors result in obesity, indicating
the importance of the hormone in body mass homeostasis
[32]. Leptin levels positively correlate with fasting insulin,
fasting glucose, and triglycerides in nondiabetic men [33].
Studies show leptin increases adult hippocampal neurogen-
esis mainly by increasing cell proliferation and not by pro-
moting cell diﬀerentiation and survival and reduces body
weight (inversely correlated with cell diﬀerentiation) of ani-
mals [34]. By contrast, our study demonstrated that weight
was inversely correlated with diﬀerentiation, as reﬂected by
the generation of new neurons and survival, indicated by
BCL-2 expression, but there was no correlation between
weight and cell proliferation. The discrepancy between our
ﬁndings and others may be due to multiple factors, such as
diﬀerences in species, studies, and interventions.
To our knowledge, this is the ﬁrst study to show cor-
relation between neurogenesis and metabolic parameters in
nonhuman primates. There are several limitations of this
study, including the small sample size and the inability to
reveal a causal link between central and metabolic process.
Further studies should investigate the relationship between
neuroplasticity and peripheral metabolic processes.
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